- Report
- August 2025
- 194 Pages
Global
From €5223EUR$5,850USD£4,569GBP
- Report
- August 2025
- 179 Pages
Global
From €5223EUR$5,850USD£4,569GBP
- Report
- August 2025
- 174 Pages
Global
From €5223EUR$5,850USD£4,569GBP
- Report
- August 2025
- 158 Pages
Global
From €5223EUR$5,850USD£4,569GBP
- Report
- August 2025
- 638 Pages
Global
From €5223EUR$5,850USD£4,569GBP
- Report
- August 2025
- 267 Pages
Global
From €5223EUR$5,850USD£4,569GBP
- Report
- August 2025
- 581 Pages
Global
From €5223EUR$5,850USD£4,569GBP
- Report
- January 2025
- 182 Pages
Global
From €4017EUR$4,500USD£3,515GBP
- Report
- January 2025
- 180 Pages
Global
From €4017EUR$4,500USD£3,515GBP
- Report
- January 2025
- 182 Pages
Global
From €4017EUR$4,500USD£3,515GBP
- Report
- January 2025
- 182 Pages
Global
From €4017EUR$4,500USD£3,515GBP
- Report
- November 2024
- 180 Pages
Global
From €4017EUR$4,500USD£3,515GBP
- Report
- December 2024
- 135 Pages
Global
From €3526EUR$3,950USD£3,085GBP
- Report
- March 2025
- 150 Pages
Global
From €3437EUR$3,850USD£3,007GBP
€4330EUR$4,850USD£3,788GBP
- Report
- August 2024
- 200 Pages
Global
From €4418EUR$4,949USD£3,865GBP
- Report
- July 2025
- 93 Pages
Global
From €3500EUR$4,200USD£3,169GBP
- Report
- April 2025
- 95 Pages
Global
From €3500EUR$4,200USD£3,169GBP
- Report
- June 2025
- 195 Pages
Global
From €4459EUR$4,995USD£3,901GBP
- Report
- June 2025
- 267 Pages
Global
From €4459EUR$4,995USD£3,901GBP
- Report
- January 2025
- 240 Pages
Global
From €4459EUR$4,995USD£3,901GBP

The Immunosorbent Assay (ELISA) market is a segment of the Diagnostics industry that focuses on the detection and quantification of antigens and antibodies in biological samples. ELISA is a laboratory technique used to detect and measure the presence of specific proteins, hormones, and other molecules in a sample. ELISA tests are used to diagnose a variety of medical conditions, including autoimmune diseases, allergies, and infections. ELISA tests are also used to detect the presence of drugs and toxins in the body.
The ELISA market is driven by the increasing prevalence of chronic diseases, the growing demand for point-of-care testing, and the increasing demand for personalized medicine. The market is also driven by technological advancements in the field of diagnostics, such as the development of automated ELISA systems.
Some of the major companies in the ELISA market include Abbott Laboratories, Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, and Roche Diagnostics. Show Less Read more